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been promising. Of interest, 33% of the deceased patients 
had typical or atypical chest pain the days before the lethal 
event.  Conclusion: A large percentage of AMI patients who 
died soon after hospitalization were in critical circulatory 
state directly before hospitalization. In 37%, in-hospital re-
suscitation attempts were omitted for understandable rea-
sons. Options for improvement in acute care in the investi-
gated setting were not found. However, in one third of the 
cases earlier preventive measures might have been reason-
able.  Copyright © 2010 S. Karger AG, Basel
 Introduction
 In-hospital mortality from acute myocardial infarc-
tion (AMI) has been shown to have decreased during re-
cent years  [1–3] . This was attributed to the timely and 
intensive adoption of advanced acute care including im-
proved therapeutic strategies as well as improved logistics 
in seeking patients who might benefit. 
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 Abstract
 Objectives: To provide valid clinical data of early in-hospital 
deaths with presumed acute myocardial infarction (AMI) 
who are often not included in clinical trials or registries. 
 Methods: From August 2004 to August 2006 all patients (age 
25–84 years) dying within 24 h after hospitalization in a large 
tertiary care academic teaching hospital were screened re-
garding an underlying cardiovascular cause of death.  Re-
sults: After validation, 79 out of 1,352 patients remained with 
a final diagnosis of AMI. Sixty-six percent of these experi-
enced prehospital cardiac arrest or shock. In 37% no resus-
citation attempts were performed in-hospital, the most 
common reason being multimorbidity. Only 23% could be 
transferred to coronary angiography for revascularisation at-
tempts. An independent panel of clinicians judged that only 
in one patient would another management strategy have 
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 Most of the data stem from clinical trials performed 
during different time periods, registries or from admin-
istrative data with more or less consecutive and complete 
patient data acquisition. Thus, similar to the out-of-hos-
pital setting, in many studies and registries the usual lack 
of availability of valid clinical data in early in-hospital 
deceased patients may lead to the exclusion of patients 
who died during the first 24 h after hospitalization  [4] . 
Accordingly, many of the data showing improved in-hos-
pital case fatality may only be able to show the effects of 
improvements in care for patients who already have sur-
vived the critical first hours. This is underscored by the 
observation of a relatively low in-hospital case fatality in 
clinical studies or registries  [5, 6] . Thus, especially in phy-
sician self-reported AMI registries this phenomenon may 
lead to an under-registration of early occurring AMI-
related deaths  [7] . Accordingly, it could be shown that 
around 70% of all 28-day fatal cases occur during the first 
24 h using a broader-based epidemiological AMI defini-
tion, versus a proportion of only 19% when using a clini-
cal-based definition  [4] . 
 Thus, little is known about the magnitude and cir-
cumstances of early occurring in-hospital AMI-related 
deaths. Since this has been claimed to be a prominent 
‘scientific gap’ in our knowledge of potentially AMI-re-
lated sudden cardiac death  [8] , the aims of the present 
study were to (1) prospectively evaluate whether a pre-
sumed in-hospital cardiovascular (CVD)-related death is 
due to a real AMI in a large tertiary care community-
hospital; (2) investigate the characteristics of early deaths, 
and (3) consider whether early deaths may have been pre-
ventable by a different management strategy. The per-
spective of the study was from the hospital, to evaluate 
the circumstance of early in-hospital death, but not pri-
marily to follow all patients with survival after out-of-
hospital cardiac arrest which requires another strategy. 
In addition, we compared the prospectively gained data 
(August 2004 to August 2006) with a representative sam-
ple of all early deceased AMI patients in the same hospi-
tal over a previous period of 20 years.
 Methods
 The population-based Augsburg Coronary Event Registry was 
implemented in October 1984 as part of the World Health Orga-
nization’s MONICA project (Monitoring Trends and Determi-
nants on Cardiovascular Diseases)  [9] . Since 1996 the registry has 
been carried on within the framework of KORA (Cooperative 
Health Research in the Region of Augsburg). All cases of fatal 
coronary events and non-fatal AMIs of the 25- to 74-year-old in-
habitants of the city of Augsburg and the two adjacent counties 
(about 400,000 inhabitants) are continuously registered. Methods 
of case finding, diagnostic classification of events and data qual-
ity control have been described elsewhere  [4, 9, 10] . We followed 
all patients with a suspected diagnosis of AMI who were hospital-
ized in the study region’s major clinic (Klinikum Augsburg, aca-
demic teaching hospital of the University of Munich and tertiary 
care centre offering angiography, PCI, as well as heart surgery fa-
cilities on a 24-hour/365-day basis) in which approximately 85% 
of all AMI cases of the study region are treated. The study was ap-
proved by the ethics committee of the Bavarian Medical Associa-
tion.
 For the presently analyzed time period (August 2004 to Au-
gust 2006) 795 fatal and nonfatal 25- to 75-year-old patients with 
a validated diagnosis of AMI hospitalized in the Klinikum Augs-
burg were registered by the MONICA/KORA registry using the 
usual, previously described screening and validation process  [4, 
9, 10] . Inclusion of 75- to 84-year-old patients was performed over 
one year in the same study period and revealed an additional 
amount of fatal and non-fatal AMI patients of 238 a year (that is 
around 475 additional elderly AMI cases during the two-year 
study period).
 The present report focuses on all early deceased ( ^  24 h) pa-
tients who died in the Klinikum Augsburg from August 2004 to 
August 2006. Patients who were referred from other hospitals 
were not included.
 To avoid missing any possible fatal coronary event, in addition 
to the usual screening process, every patient who died in the 
Klinikum Augsburg was identified in the pathology book on a 
daily basis. From all patients dying  ! 24 h after admission, all cas-
es with a potential cardiovascular cause of death were extracted. 
Comparison of these independently gathered data revealed that 
most of the possible fatal coronary events identified were also 
counted by the usual MONICA/KORA screening process (n = 90) 
by which diagnostic categorization was done retrospectively sev-
eral weeks after the occurrence of death by gaining postal infor-
mation from last treating physcians and/or coroners  [4] . From 
these 90 patients, after validation 67 patients remained as definite, 
probable or possible fatal AMI. An additional number of 12 pa-
tients, not classified as cardiovascular death-related by the usual 
MONICA/KORA screening process, were identified by this pro-
spective approach.
 For all these patients, standardized information was sought by 
a study physician from chart review and interviews from the last 
treating physicians and/or nurses in the ambulance, the emer-
gency department, the coronary care unit or on the general ward, 
as well as from family physicians, and coroners or medical exam-
iners and next of kin and other informants. Autopsies were un-
dertaken in two patients only, since autopsy rates in Germany for 
those who die in old age are traditionally low  [4] . In 60% of all 
early deceased patients an ECG shortly before the occurrence of 
death was available, in 70% first laboratory results including cre-
atinine-kinase and troponin, and in 90% information regarding 
the last hours before death were available from chart review and 
interviews of the last treating physician/ambulance personal, 
nurses or next of kin. 
 First Study Objective
 To evaluate whether a presumed in-hospital CVD-related 
death is due to a real AMI, a panel of three physicians reviewed 
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each fatal case by using all the above-mentioned information. 
Disagreements were adjudicated by the committee chairman 
(B.K.). Classification was performed using the criteria proposed 
by the Joint Committee of the European Society of Cardiology 
and American College of Cardiology and other societies and re-
search agencies to improve the consistency of case definitions in 
epidemiological and clinical studies: ‘definite fatal AMI’, ‘proba-
ble fatal AMI’ or ‘possible fatal coronary event’  [11] .
 Second Study Objective
 For all patients classified as having an AMI-related death, the 
characteristics and circumstances of death were investigated re-
garding history, place of in-hospital death, and background of 
CPR measures.
 Third Study Objective
 In addition, after reviewing the collected data, the panel gave 
a judgment regarding the appropriateness of the therapeutic strat-
egy. All cases where an initial incorrect diagnosis had been made 
or an indicated timely invasive strategy would have been promis-
ing were considered as being candidates for  a different treatment 
strategy.
 Cases in whom at no point in time an appropriate circulation 
could have been achieved or who have been found dead in bed 
with no indicated resuscitation (CPR) efforts, as well as those in 
whom CPR was withheld due to multimorbidity were not consid-
ered as candidates for  other therapy. Therapeutic hypothermia 
was not considered as a therapy option because it had not been 
implemented at the time of this study. 
 In addition, for comparison with earlier years, data gathered 
retrospectively were used for investigating the years 1985 until 
2004. The data ascertainment and validation processes are de-
scribed in detail elsewhere  [7] . Briefly, all patients with a potential 
CVD-related death who were identified by screening death cer-
tificates of all deceased within the study region were validated by 
sending standardized questionnaires two to four weeks after the 
date of death to the last attending physician and/or coroner (re-
sponse rate  1 90%). From all those patients who died in the Klini-
kum Augsburg during the first 24 h from presumed beginning of 
symptoms (n = 2,076) we took a 19% random sample (n = 391) for 
an intensified validation process similar to that adopted in the 
prospective study. The study sample was divided into five 4-year 
periods (1985–1988, 1989–1992, 1993–1996, 1997–2000, 2001–
2004). In the 204 patients with validated AMI according to the 
above-mentioned criteria, the same panel of three physicians also 
gave a judgment regarding the appropriateness of the therapeutic 
strategy by applying the same criteria and taking ‘modern’ infarc-
tion therapy as the basis.
 Statistical Analysis
 The associations between time periods and the judgment 
about the appropriateness of the therapeutic strategy were exam-
ined using logistic regression, while modeling time periods as an 
11-level categorical variable simultaneously adjusting for age and 
sex and giving the p for trend. p values  ! 0.05 were considered as 
statistically significant. Due to the low numbers, we decided not 
to present the data separately for men and women. All analyses 
were carried out with the SAS  system for Windows release 9.1. 
 Results
 Classification and Timing of In-Hospital Deaths 
 During the observation period, 3,736 patients were 
identified who died in the Klinikum Augsburg. After ex-
clusion of 2,384 patients who died  1 24 h after hospitaliza-
tion – with the exception of patients originally hospital-
ized with a diagnosis other than CVD who died in hos-
pital due to a presumable CVD death  ^  24 h after 
symptom onset – 1,352 patients remained who died
 ^  24 h. Those were screened for a potential underlying 
cardiovascular cause of death. This is graphically illus-
trated in  figure 1 . 
 After first screening to exclude patients who clearly 
had died of causes other than CVD, 117 patients remained 
Patient death in the hospital during the observation
period of 24 months 
n = 3,736 
Death during the first 24 h after hospitalization
n = 1,352
Patients with potential CVD-related death
after first screening
n = 117
Patients with a ‘real AMI’ after validation
n = 79
Death >24 h after hospitalization
n = 2,384
6 patients with other cardiac cause of death
7 patients with known CHD, but no signs of acute
 ischemia (mostly ischemic CMP)
12 patients with non-cardiac cause of death
13 patients where cause of death remains unclear Fig. 1. Identification of time and cause of 
death occurring in-hospital during the ob-
servation period. 
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for intensified evaluation, resulting in 79 patients who 
were deemed to have AMI as the death-causing event (49 
with definite, 17 with probable, and 13 with possible fatal 
AMI). 
 Characteristics of Early Deceased Patients with a 
Validated AMI
 The age range was from 41 to 84 years (mean 70.9  8 
9.6), 50 were male (63.3%).  Table 1 shows the characteris-
tics of the patients.  While 13 (16%) patients were already 
hospitalized, the majority (83%) came into hospital by the 
emergency system, with the exception of one patient who 
came to the emergency department by himself.
 Patients Already Hospitalized (n = 13). The original 
reason for hospitalization was stable coronary artery dis-
ease in four patients, peripheral artery disease in four pa-
tients, diabetes mellitus in three patients, and abdominal 
surgery in two patients.
 Patients Hospitalized by Emergency System (n = 65). 
From all patients who originally reached the hospital by 
the emergency system, the initial ECG derived by the 
emergency team showed ventricular fibrillation or flutter 
in 18 (28%) patients, and in 13 (20%) of patients asystolic 
or pulseless electrical activity. Forty-three (66%) patients 
had a prehospital cardiac arrest or cardiogenic shock, and 
in 37 (57%) prehospital CPR attempts have been made 
(CPR duration: mean 36  8 12 min, median 40 min). In 
32 cases with prehospital CPR, information about time 
from cardiac arrest until beginning of CPR attempts were 
available: in 24 (75%) of these patients the presumed time 
period from onset of cardiac arrest to arrival of profes-
sional medical help was less than 10 min. 
 Table 1. C haracteristics of early deceased patients with a validated 
AMI (n = 79)
 n  % 
 Age, years (mean)  70.9 8 9.6 – 
 Sex, male  50  63.3 
 Medical history 
 History of hyperlipidemia  47  59.5 
 History of diabetes  43  54.4 
 History of hypertension  62  78.5 
 Active smoking 8  10.1 
 History of coronary artery disease  37  46.8 
 Previous myocardial infarction  26  33.8 
 History of cerebrovascular disease  17  21.5 
 History of peripheral artery disease  14  17.7 
 History of chronic pulmonary disease 9  11.4 
 History of malignant tumor  15  19.0 
 Known EF <40%  17  21.5 
 
 
 Table 2. P lace of in-hospital death
 All patients (n = 79)  n  % 
 Emergency room  23  29.1 
 Coronary care unit  38  48.1 
 General ward  16  20.3 
 During coronary intervention 1 1.3 
 During CABG surgery 1 1.3 
 
 
 Table 3. R easons for withholding CPR
 All patients without CPR (n = 29)  n  % 
 Multimorbidity  12  41.4 
 Hypoxic encephalopathy  3  10.3 
 Only catecholamines  12  41.4 
 Found dead with significant time elapsed





 Table 4.  Judgment about appropriateness of therapeutic strategy
 All patients (n = 79)  % 
 Other strategy might have been more successful 1  1  1.3 
 No better strategy available because no
 stable circulation at any time (ongoing CPR) 2 
 48  60.8 
 No better strategy, because best available
 strategy has been provided or was not indicated
 (e.g. multimorbidity) 3 
 29  36.7 
 No judgment possible  1  1.3 
 1  Patient was hospitalized with non-ST-elevation MI with, 
however, high-risk features (dynamic ECG-changes, diabetes and 
ongoing chest pain), but the performance of early coronary angi-
ography was missed.
 2  Performance of CPR was considered optimal, further strate-
gies like invasive coronary investigation and/or emergency appli-
cation of extracorporeal circulatory support was deemed inap-
propriate/impossible.
 3  Patients who died despite optimal therapy or patients where 
notations in charts or interview of death-bystanders revealed se-








 In 60 patients (76%), a 12-lead ECG shortly before 
death was available (cases with no ECG were due to ongo-
ing resuscitation attempts or in those found dead with 
significant time elapsed after dying). Most had ST eleva-
tion (46%) or bundle branch block (32%).  Table 2 shows 
the place where death occurred.
 In 50 patients (63%) CPR attempts were provided in-
hospital. The reasons for withholding CPR for the other 
29 patients are given in  table 3 . The most common rea-
sons were multimorbidity or strong hints for hypoxic
encephalopathy (51%). Treatment ‘only with catechol-
amines’ means that patients were treated in the CCU only 
with catecholamines without additional mechanical or 
electrical CPR activities because they were supposed to 
have no chance for myocardial recovery, including those 
patients who have been already revascularized or treated 
with an intra-aortic balloon pump.
 In only 18 (23%) patients could a coronary angiogra-
phy be performed, with primary PCI in 11/18 and emer-
gency CABG in 3/18. In 6 patients (8%) thrombolyis (pre-
hospital or early-inhospital) was provided; 9 (11%) pa-
tients were treated with intra-aortic balloon pump. In 24 
patients an echocardiogram shortly before death was ob-
tainable, where 15 patients showed a severely impaired 
global contractile function, 3 patients a hemodynamical-
ly significant pericardial effusion, and 1 patient a ven-
tricular septal defect.
 Evaluation of the patient history revealed that 34% had 
a previous MI and 21% had a previously documented EF 
 ! 40% (with and without a history of previous MI). Of 
note, 26 patients (33%) had typical or atypical chest pain 
the days before the lethal event, four of those did refuse 
further diagnostic workup.
 Table   gives the judgment about appropriateness of 
therapeutic strategy given by an independent panel of cli-
nicians.
 The same panel also retrospectively judged about the 
appropriateness of therapy from a sample of validated 
 ^  24-hour in-hospital AMI deaths in 25- to 75-year-old 
patients in the years 1985–2004 (n = 203) using the same 
criteria while taking modern infarction management as 
the basis. Accordingly, an optional other therapy was 
judged to have been possible in 63, 54, 41,17 and 12% of 
patients for the years 1985–1988, 1989–1992, 1993–1996, 
1997–2000, and 2001–2004, respectively (logistic regres-
sion analysis p  ! 0.001 for trend;  fig. 2 ).
 Discussion
 While, over recent years, a decrease of in-hospital 
mortality could be shown in many clinical studies as well 
as registries, the magnitude was small due to a low base-
line mortality of AMI patients who reached the hospital 
 [3] . Numerous clinical trials, directed to improve in-hos-
pital mortality, resulted in only small percentage mortal-
ity reductions, e.g. from 3.1 to 2.1% absolutely, due to the 
strict inclusion criteria  [5] .
 By using another approach of prospective case finding 
and classification, we  [9] as well as others  [12] could show 
that the real in-hospital AMI case fatality is higher than 
supposed because – due to the fact of missing data clas-
sifying those deaths as AMI related – in most studies ear-
ly occurring deaths are not counted. In an earlier retro-
spective analysis we were able to show that the decrease 
of early in-hospital deaths was particularly responsible 
for the tremendous fall in 28-day case fatality over the last 
20 years which, however, still amounts to 11%  [9] . The 
question remains whether under modern circumstances 
and therapy there are still options for improvement in 
early deceased patients not included in clinical trials or 
many registries. In the present study, we prospectively 
identified all early fatal possible AMI cases, analyzed the 
characteristics of these cases and potential other treat-
ment options. Due to the prospective nature of the study 
and the application of very strict ascertainment criteria 
by timely investigation of all in-hospital cases of deaths, 
we could be certain not to miss any CHD-related deaths, 
and to optimally reveal the circumstances of death, al-

























1985–1988 1989–1992 1993–1996 1997–2000 2001–2004 2005–2006
Years
 Fig. 2. Appropriateness of therapeutic strategy. Proportion of pa-
tients where an independent panel of clinicians judged that an-
other therapy option would have been possible, based on modern 
AMI treatment strategies. 
4
 Kuch  /von Scheidt  /Kling  /Ehmann  /
Greschik  /Meisinger 
Cardiology 2010;116:237–244242
as identification of severity, therapy or potentially missed 
therapy. To our knowledge, we are the first to use such a 
comprehensive and timely investigation of presumed ear-
ly in-hospital CHD-related deaths. 
 Although in the emergency setting it is often difficult 
to obtain valid clinical and electrocardiographic data, we 
could show that most of the patients with interpretable 
ECGs had ST elevation or bundle branch block AMI, un-
derscoring the importance of these ECG manifestations 
as a high-risk feature, especially in the acute phase  [14, 15] .
 In this prospective evaluation, we could confirm the 
trend seen in our earlier retrospective investigation that 
the proportion of very-high-risk patients – i.e. those with 
prehospital resuscitation or cardiogenic shock – was high 
and increased over time, suggesting that only those who 
died had no meaningful therapeutic option. This is un-
derscored by the fact that, although most of the patients 
were under direct medical supervision (77% died either 
in the emergency room or on the coronary care unit), 
only 23% could be transferred to coronary angiography 
with consecutive revascularization attempts. The other 
patients either were under continuous resuscitation and 
could not be stabilized enough to get them into the 
cathlab or were patients in whom no CPR attempts have 
been provided (37% of all patients). In the latter the most 
common reasons why no CPR was attempted were mul-
timorbidity or clinical judgment of no chance for recov-
ery. We are not aware of similar investigations in the in-
hospital setting. In a prospective study investigating all 
sudden cardiac deaths, the proportion of patients where 
no CPR attempts have been undertaken was 33%; how-
ever, most of the deaths occurred out of hospital, and only 
53% were witnessed. Therefore, detailed information 
about circumstance of deaths and reasons for withhold-
ing CPR were not available  [16] . Of note, although a sig-
nificant number of early occurring in-hospital deaths 
were cases who were survivors of an out-of-hospital car-
diac arrest, the present study was not a primary investi-
gation about out-of-hospital-cardiac-arrest survivors, 
which would require another study design and is beyond 
the scope of the present article.
 Of interest, taking all this information together, the 
judgment about appropriateness of therapeutic strategy 
given by an independent panel of clinicians revealed that 
only in one patient would another strategy have been 
promising, and the comparison with a retrospectively 
collected sample of early deaths revealed that this propor-
tion dramatically decreased during the last 22 years. The 
most common reason for judging particular medical care 
cases during the previous 22 years to be inappropriate 
was missing early invasive therapy in patients presenting 
with cardiogenic shock or after prehospital resuscitation 
where it would have been reasonable  [17] as well as pos-
sible (no ongoing CPR at presentation; data not shown). 
This also can be seen in our earlier analysis of the overall 
MI population where, for example, it could be shown that 
PCI procedures were performed in 30% in 1998 as com-
pared to 66.0% in 2004  [18] . 
 This observation allows two different interpretations: 
first, the dramatic fall in in-hospital mortality may large-
ly be due to improvements in the acute care of critically ill 
patients in the early phase, and, in fact, earlier analysis 
from our studies showed that 28-day case fatality from
in-hospital cases, when using validated clinical AMI
criteria, decreased from 23% in 1985/1986 to 11% in 
2005/2006  [7] . Secondly, nowadays – in the setting of a 
well-organized tertiary care centre – there seems to re-
main little space for further improvements beyond the es-
tablished primary PCI strategy and optimal therapy for 
cardiogenic shock in CPR survivors  [18] . On the other 
hand, it remains to be proven whether the more wide-
spread application of more advanced mechanical circula-
tory support systems (including extracorporeal life sup-
port  [19] ), which were rarely applied in our institution and 
were not considered an appropriate treatment option in 
the investigated population, may add to further mortality 
reductions. We have no data about the appropriateness of 
CPR measures in the 57% of patients with prehospi - 
tal CPR. However, the fact that the presumed time
period from onset of cardiac arrest to arrival of profes-
sional medical help was less than 10 min in 75% of cases 
is in concordance with German law demanding arrival of 
emergency personal in less than 15 min in the majority of 
cardiac patients. This may indicate the effectiveness of the 
region’s emergency system and also be due to the fact that 
the majority of prehospital cardiac arrests were witnessed.
 On the other hand, the fact that 33% of the deceased 
patients have had typical or atypical angina pectoris com-
plaints the days before the lethal event and four of those 
did refuse further diagnostic workup is alarming, and 
contradicts previous assumptions of sudden death pa-
tients who were assumed to mainly have been asymptom-
atic before the lethal event  [20] . Accordingly, improve-
ments in public and professional education about alarm-
ing symptoms indicating a need for immediate workup 
may be possible.
 Limitations
 It may be argued that the judgment about appropriate-
ness of therapy is prone to be subjective. However, there 
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was an objective catalogue of criteria given to the panel, 
helping them to make their judgment as objective as pos-
sible. However, we cannot exclude the possibility that the 
judgment of the retrospective data may be more biased 
because timely information was less available and less 
complete than in the prospectively gained data. Despite a 
high percentage of available information about the cir-
cumstances of death, we cannot rule out that information 
regarding previous complaints about angina in the days 
before the lethal event is incomplete, and the number of 
33% with typical or atypical angina pectoris complaints 
could be an underestimate. Finally, the upper limit of age 
was 85 years, and we have no data about numbers and po-
tentially missed opportunities in this very old age group.
 Conclusions
 AMI patients with an early occurring in-hospital 
death have a pre-existing high-risk profile with pre-hos-
pital cardiac arrest or cardiogenic shock in 66%. There 
are barely any options for improvement in acute care in 
these patients in the investigated setting (tertiary care 
centre). In 37% of the patients, there were no in-hospital 
CPR attempts undertaken for understandable reasons. In 
the view of primary prevention, however, in about one 
third of these patients earlier diagnostic and therapeutic 
measures might have been reasonable.
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